FR3053339B1 - BIOMARKER FOR THE DIAGNOSIS OF CHRONIC INFLAMMATORY DISEASES OF THE INTESTINE - Google Patents
BIOMARKER FOR THE DIAGNOSIS OF CHRONIC INFLAMMATORY DISEASES OF THE INTESTINE Download PDFInfo
- Publication number
- FR3053339B1 FR3053339B1 FR1656344A FR1656344A FR3053339B1 FR 3053339 B1 FR3053339 B1 FR 3053339B1 FR 1656344 A FR1656344 A FR 1656344A FR 1656344 A FR1656344 A FR 1656344A FR 3053339 B1 FR3053339 B1 FR 3053339B1
- Authority
- FR
- France
- Prior art keywords
- diagnosis
- biomarker
- chronic inflammatory
- intestine
- inflammatory diseases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
- C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/91—Transferases (2.)
- G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- G01N2333/91205—Phosphotransferases in general
- G01N2333/9121—Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases
- G01N2333/91215—Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases with a definite EC number (2.7.1.-)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/06—Gastro-intestinal diseases
- G01N2800/065—Bowel diseases, e.g. Crohn, ulcerative colitis, IBS
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
L'invention concerne l'utilisation d'un biomarqueur pour le diagnostic d'une maladie inflammatoire chronique de l'intestin, une méthode de diagnostic, une méthode d'évaluation de l'efficacité d'un traitement, une méthode de dosage, ainsi que des kits et des substrats enzymatiques.The invention relates to the use of a biomarker for the diagnosis of chronic inflammatory bowel disease, a method of diagnosis, a method of evaluating the efficacy of a treatment, a method of assay, and so on. as kits and enzyme substrates.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1656344A FR3053339B1 (en) | 2016-07-01 | 2016-07-01 | BIOMARKER FOR THE DIAGNOSIS OF CHRONIC INFLAMMATORY DISEASES OF THE INTESTINE |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1656344A FR3053339B1 (en) | 2016-07-01 | 2016-07-01 | BIOMARKER FOR THE DIAGNOSIS OF CHRONIC INFLAMMATORY DISEASES OF THE INTESTINE |
FR1656344 | 2016-07-01 |
Publications (2)
Publication Number | Publication Date |
---|---|
FR3053339A1 FR3053339A1 (en) | 2018-01-05 |
FR3053339B1 true FR3053339B1 (en) | 2021-04-23 |
Family
ID=56943748
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR1656344A Expired - Fee Related FR3053339B1 (en) | 2016-07-01 | 2016-07-01 | BIOMARKER FOR THE DIAGNOSIS OF CHRONIC INFLAMMATORY DISEASES OF THE INTESTINE |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR3053339B1 (en) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2811000A1 (en) * | 2010-09-09 | 2012-03-15 | Traxxsson, Llc | Combination methods of diagnosing cancer in a patient |
JP2014513949A (en) * | 2011-04-20 | 2014-06-19 | トラクソン・リミテッド・ライアビリティ・カンパニー | Methods for diagnosing cancer in patients |
US20140113306A1 (en) * | 2012-10-17 | 2014-04-24 | Rutgers, The State University Of New Jersey | Diagnostic and screening methods for inflammation |
-
2016
- 2016-07-01 FR FR1656344A patent/FR3053339B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
FR3053339A1 (en) | 2018-01-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2020001193A (en) | Methods for determining dpp3 and therapeutic methods. | |
MA40754B1 (en) | Compositions comprising bacterial strains | |
MA41060B1 (en) | Compositions comprising bacterial strains | |
MA55434B1 (en) | Compositions comprising bacterial strains | |
MA41010A (en) | COMPOSITIONS INCLUDING BACTERIAL STRAINS | |
FR3021970B1 (en) | ANTIBODY AGAINST GALECTIN 9 AND INHIBITOR OF THE SUPPRESSIVE ACTIVITY OF T REGULATORY LYMPHOCYTES | |
WO2013008102A3 (en) | Methods and compositions for evaluating and/or treating chronic immune diseases | |
BR112014011127A2 (en) | Methods for Treating, Diagnosing, and Monitoring Alzheimer's Disease | |
MA45125B1 (en) | Anti-alpha-synuclein antibodies and their uses | |
BR112017017076A2 (en) | il-18 inhibitor, antibody, methods for treating an il-18 associated disease or disorder in an individual, to determine the amount of free il-18 in a sample or in situ, to diagnose a predisposition to a disease or an il-18 associated disorder, to monitor minimal residual disease in a patient following treatment with the il-18 inhibitor or composition and to predict a patient's response to treatment with the il-18 inhibitor or composition, and diagnostic kit to detect free il-18. | |
MX347853B (en) | A rapid quantitative assay to measure cftr function in a primary intestinal culture model. | |
NZ729773A (en) | Biomarkers for disease progression in melanoma | |
BR112017025995A2 (en) | igfbp3 inhibitor, pharmaceutical composition for use in the treatment and / or prevention of an intestinal disorder, method for the diagnosis of an intestinal disorder in an individual and kit for the diagnosis of an intestinal disorder | |
MX2018001697A (en) | Method for the quantification of faecalibacterium prausnitzii phylogroup i and/or phylogroup ii members and the use thereof as biomarkers. | |
EP3974450A3 (en) | Biomarker | |
IN2014DN08537A (en) | ||
WO2015013508A3 (en) | Methods for diagnosing and treating immune disease | |
FR2986538B1 (en) | USE OF MIR-199A-5P OF ITS TARGETS AND / OR INHIBITORS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF FIBROPROLIFERATIVE DISEASES | |
BR112015021507A8 (en) | Methods and Compositions for the Diagnosis of Preeclampsia in a Pregnant Woman and Diagnostic Test Kit | |
FR3053339B1 (en) | BIOMARKER FOR THE DIAGNOSIS OF CHRONIC INFLAMMATORY DISEASES OF THE INTESTINE | |
MX2021009247A (en) | Methods, systems, and kits for treating inflammatory disease targeting il18r1. | |
FR3053338B1 (en) | BIOMARKER FOR THE DIAGNOSIS OF INFLAMMATORY DISEASES | |
MX2018000189A (en) | Method for the diagnosis of farber's disease. | |
FR2963791B1 (en) | METHOD OF DIAGNOSING NEURODEGENERATIVE DISEASES | |
FR3049104B1 (en) | METHOD FOR DIAGNOSING CHRONIC INFLAMMATORY BOWEL DISEASES |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PLFP | Fee payment |
Year of fee payment: 2 |
|
PLSC | Publication of the preliminary search report |
Effective date: 20180105 |
|
PLFP | Fee payment |
Year of fee payment: 3 |
|
PLFP | Fee payment |
Year of fee payment: 5 |
|
PLFP | Fee payment |
Year of fee payment: 6 |
|
ST | Notification of lapse |
Effective date: 20230305 |